Quick Answer: GLP-1 medications do not directly cause muscle cramps through pharmacologic action, but some patients may experience cramping indirectly due to rapid weight loss, electrolyte disturbances, or dehydration associated with treatment
Inhibiting NNMT with 5-amino-1MQ reverses this: NAD+ levels rise, mitochondrial respiration increases, and white adipose tissue (fat storage) shifts toward thermogenesis
With hundreds of published studies, it is one of the most researched peptides in regenerative biology demonstrating systemic activity across tendons, ligaments, muscle, bone, gut epithelium, and neural tissue through the nitric oxide system, growth hormone receptor signaling, and angiogenic pathways
The most commonly reported adverse events in Phase 2 and Phase 3 trials were gastrointestinal in nature, including nausea, diarrhea, vomiting, and constipation